Ali Behbahani is of Arcellx, Inc.. Currently has a direct ownership of 339 shares of ACLX, which is worth approximately $29,835. The most recent transaction as insider was on Jun 01, 2023, when has been sold 113 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 339
0% 3M change
0% 12M change
Total Value Held $29,835

Ali Behbahani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2023
BUY
Other acquisition or disposition
-
113 Added 25.0%
339 Common Stock
Dec 20 2022
BUY
Other acquisition or disposition
-
226 Added 50.0%
226 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
MTCR
Metacrine, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
AB

Ali Behbahani

Timonium, MD

Track Institutional and Insider Activities on ACLX

Follow Arcellx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACLX shares.

Notify only if

Insider Trading

Get notified when an Arcellx, Inc. insider buys or sells ACLX shares.

Notify only if

News

Receive news related to Arcellx, Inc.

Track Activities on ACLX